A cutting-edge microdevice, comparable in size to a grain of rice, promises a revolutionary approach to treating some of the...
In a pivotal breakthrough, researchers from the University of Kentucky have revealed that ponesimod, an FDA-approved drug for multiple sclerosis...
In a groundbreaking study, Bayer's subsidiary, BlueRock Therapeutics, revealed positive early-stage results for its stem cell therapy aimed at treating...
In a significant leap forward in Alzheimer's disease (AD) research, scientists from Massachusetts General Hospital (MGH) have developed a groundbreaking 3D cellular model.Read more
Groundbreaking a new study reveals that smartwatches can detect Parkinson's disease seven years before symptoms arise, offering a glimmer of hope in its early diagnosis and treatment.Read more
Aneurysm is swelling or enlargement of an arterial wall due to weakening of the vascular wall. Aneurysms in the heart and brain region are very dangerous.Read more
Parkinson’s disease is a slow progressing neurological disorder that is generally seen between 55 and 65 years of age and causes damage to brain cells.Read more
Alzheimer’s disease is a type of dementia that causes memory, thinking and behavior problems. It is the most common reasons of dementia.Read more
Epilepsy is a type of brain disease that causes recurrent seizures; erroneous signal transmission of nerve cells or neuron clusters in the brain leads to seizures.Read more
Hydrocephalus is a chronic and neurological disease caused by the over-accumulation of cerebrospinal fluid. It can be seen at any age, including newborns.Read more
Ischemia is a serious condition in which blood flow to any organ in the body is stopped. During ischemia, blood vessels providing oxygen to brain, is blocked.Read more